Suchergebnisse - "Famiglietti, V"

PubPharm (2)

1

Cetuximab as third-line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild-type circulating tumor DNA : Individual patient data pooled analysis of CRICKET and CAVE trials

enthalten in: Cancer medicine | 2023

von Martini, G. | Ciardiello, D. | Famiglietti, V. | +19

2

Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer : findings from a real-life multicenter Italian study (CRC-KR GOIM)

enthalten in: ESMO open | 2022

von Ciardiello, D. | Chiarazzo, C. | Famiglietti, V. | +31

1
[1]